QA: BIOXYTRAN INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2022_BIOXYTRAN_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001445815')"}

Graph

Absolute values for 0001445815, BIOXYTRAN INC

  xvar xval
0 AssetsCurrent 72,358
1 IntangibleAssetsNetIncludingGoodwill 46,932
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 3,277,497
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,617,810
9 ResearchAndDevelopmentExpense 2,013,762
10 remainder_Expenses 582,862
11 remainder_Revenues 0
12 remainder_NetIncome -313,608
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 119,290
1 Liabilities 3,277,497
2 Expenses 4,214,434
3 Revenues 0
4 StockholdersEquity -3,158,207
5 NetIncome -4,528,042
6 ComprehensiveNetIncome -4,528,042
7 BaseVar 3,962,414
8 EconomicCapitalRatio -5.86

Edgar->Model Mapping

Feature Distribution

Change over Time